ES2663019T3 - Cepa de E. coli F18 no patógena y uso de la misma - Google Patents

Cepa de E. coli F18 no patógena y uso de la misma Download PDF

Info

Publication number
ES2663019T3
ES2663019T3 ES13819873.4T ES13819873T ES2663019T3 ES 2663019 T3 ES2663019 T3 ES 2663019T3 ES 13819873 T ES13819873 T ES 13819873T ES 2663019 T3 ES2663019 T3 ES 2663019T3
Authority
ES
Spain
Prior art keywords
coli strain
strain
live
coli
pathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13819873.4T
Other languages
English (en)
Spanish (es)
Inventor
John Morris Fairbrother
Éric NADEAU
Clarisse DESAUTELS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prevtec Microbia Inc
Original Assignee
Prevtec Microbia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevtec Microbia Inc filed Critical Prevtec Microbia Inc
Application granted granted Critical
Publication of ES2663019T3 publication Critical patent/ES2663019T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES13819873.4T 2012-07-20 2013-07-18 Cepa de E. coli F18 no patógena y uso de la misma Active ES2663019T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261674179P 2012-07-20 2012-07-20
US201261674179P 2012-07-20
PCT/CA2013/000660 WO2014012172A1 (en) 2012-07-20 2013-07-18 Non-pathogenic f18 e. coli strain and use thereof

Publications (1)

Publication Number Publication Date
ES2663019T3 true ES2663019T3 (es) 2018-04-10

Family

ID=49948133

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13819873.4T Active ES2663019T3 (es) 2012-07-20 2013-07-18 Cepa de E. coli F18 no patógena y uso de la misma

Country Status (17)

Country Link
US (3) US9453195B2 (enExample)
EP (1) EP2875121B1 (enExample)
JP (1) JP6278960B2 (enExample)
KR (1) KR102171028B1 (enExample)
CN (1) CN104736695B (enExample)
BR (1) BR112015001175B1 (enExample)
CA (1) CA2879155C (enExample)
DK (1) DK2875121T3 (enExample)
ES (1) ES2663019T3 (enExample)
HU (1) HUE036545T2 (enExample)
MX (1) MX363057B (enExample)
PH (1) PH12015500091A1 (enExample)
PL (1) PL2875121T3 (enExample)
PT (1) PT2875121T (enExample)
RS (1) RS57056B1 (enExample)
RU (1) RU2670882C9 (enExample)
WO (1) WO2014012172A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102171028B1 (ko) 2012-07-20 2020-10-28 프레브테크 마이크로비아 인코포레이티드 비 병원성 f18 대장균 균주 및 이의 용도
MX384826B (es) * 2015-02-11 2025-03-14 Evah Nutrition Inc Matriz seca mejorada para incrustar escherichia coli viable, metodo para hacer la misma y uso de la misma.
KR101715625B1 (ko) * 2015-06-02 2017-03-13 대한민국(농림축산식품부 농림축산검역본부장) 부종병 독소를 생산하는 대장균, 이를 이용한 부종병 독소의 생산방법 및 이를 포함하는 돼지 부종병 예방용 백신 조성물
CA3027896C (en) * 2016-06-14 2021-07-13 Prevtec Microbia Inc. Animal feed pellets including a feed additive, method of making and of using same
US20200113950A1 (en) * 2017-06-30 2020-04-16 The Rockefeller University Human microbiota derived N-acyl amides for the treatment of human disease
CN107523529B (zh) * 2017-10-20 2021-03-12 林州中农颖泰生物肽有限公司 一种利用大肠杆菌生产肠杆菌肽的工艺及其应用
CN109628361B (zh) * 2018-11-27 2022-08-19 扬州大学 整合双拷贝功能性f4菌毛操纵子基因猪源益生菌ep1克隆株、构建方法及应用
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
CN114752531B (zh) * 2022-04-29 2023-05-26 扬州大学 一株同时表达f4和f18菌毛的猪源大肠杆菌无毒分离株及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125455C1 (ru) * 1996-09-25 1999-01-27 Саратовская научно-исследовательская ветеринарная станция Способ профилактики диареи молодняка сельскохозяйственных животных
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
IL141142A0 (en) * 1998-07-30 2002-02-10 Wisconsin Alumni Res Found Gastrointestinal bacterial antibody factories
US6304216B1 (en) 1999-03-30 2001-10-16 Conexant Systems, Inc. Signal detector employing correlation analysis of non-uniform and disjoint sample segments
HU221664B1 (hu) 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
CA2430292A1 (en) 2000-11-30 2002-06-06 The Bio Balance Corp. Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
AU2003287028B2 (en) 2002-10-04 2008-09-04 E.I. Du Pont De Nemours And Company Process for the biological production of 1,3-propanediol with high yield
CN1913787B (zh) * 2004-02-03 2014-11-26 增值研究合伙有限公司 在动物中促进生长的活体细菌的应用
CA2566617C (en) * 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
US7927586B2 (en) 2008-07-08 2011-04-19 South Dakota State University Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli
KR102171028B1 (ko) 2012-07-20 2020-10-28 프레브테크 마이크로비아 인코포레이티드 비 병원성 f18 대장균 균주 및 이의 용도

Also Published As

Publication number Publication date
EP2875121A4 (en) 2016-01-13
MX2015000905A (es) 2015-09-28
JP2015525566A (ja) 2015-09-07
US20180008651A1 (en) 2018-01-11
JP6278960B2 (ja) 2018-02-14
HUE036545T2 (hu) 2018-07-30
DK2875121T3 (en) 2018-04-16
US9775867B2 (en) 2017-10-03
US20150152377A1 (en) 2015-06-04
KR20150036698A (ko) 2015-04-07
CA2879155C (en) 2024-04-30
CA2879155A1 (en) 2014-01-23
KR102171028B1 (ko) 2020-10-28
EP2875121B1 (en) 2018-01-03
US20160361369A1 (en) 2016-12-15
PH12015500091B1 (en) 2015-03-02
RU2015105738A (ru) 2016-09-10
PH12015500091A1 (en) 2015-03-02
CN104736695B (zh) 2017-05-24
PL2875121T3 (pl) 2018-06-29
EP2875121A1 (en) 2015-05-27
RU2670882C2 (ru) 2018-10-25
BR112015001175A2 (pt) 2017-06-27
CN104736695A (zh) 2015-06-24
WO2014012172A1 (en) 2014-01-23
BR112015001175B1 (pt) 2022-03-03
HK1209780A1 (en) 2016-04-08
US9453195B2 (en) 2016-09-27
US10258654B2 (en) 2019-04-16
RU2670882C9 (ru) 2018-12-11
MX363057B (es) 2019-03-06
PT2875121T (pt) 2018-03-14
RS57056B1 (sr) 2018-05-31

Similar Documents

Publication Publication Date Title
Fairbrother et al. Colibacillosis
US10258654B2 (en) Non-pathogenic F18 E. coli strain and use thereof
Kyriakis et al. The effect of probiotic LSP 122 on the control of post-weaning diarrhoea syndrome of piglets
Rhouma et al. Post weaning diarrhea in pigs: risk factors and non-colistin-based control strategies
Hayakawa et al. Dietary administration of probiotics to sows and/or their neonates improves the reproductive performance, incidence of post‐weaning diarrhea and histopathological parameters in the intestine of weaned piglets
Kunert Filho et al. Avian Pathogenic Escherichia coli (APEC)-an update on the control
De Cupere et al. Evaluation of the effect of 3 probiotics on experimental Escherichia coli enterotoxaemia in weaned piglets
US20250034218A1 (en) Antimicrobial peptides
ES3033316T3 (en) Lactobacillus salivarus strain and its use in the prevention and treatment of post-weaning diarrhea in piglets
WO2004052379A1 (ja) 抗下痢症組成物
CN118556072A (zh) 抗菌肽
Chaudhary et al. Antagonistic Probioticity of Novel Bacterial Isolates from Pakistan against Fish Pathogen Pseudomonas fluorescens in Labeo rohita Fingerlings
Luppi et al. Escherichia
Falkow et al. Increased survival in calves of Escherichia coli K-12 carrying an Ent plasmid
HK1209780B (en) Non-pathogenic f18 e. coli strain and use thereof
Hur et al. Age-dependent competition of porcine enterotoxigenic E. coli (ETEC) with different fimbria genes
Nhi et al. SWINE COLIBACILLOSIS IN PIG
El Dimerdash et al. Studies on the effect of some probiotics in Rabbits
Duarte et al. Novel Therapeutic Strategies in Veterinary Medicine
Bustillo Early Administration of Probiotics through in Ovo Inoculation and Their Impact on Gut Microflora, Immune Response, and Growth Performance of Broiler Chicks
Sudheendra et al. Potential Application of Probiotics for Human Health Benefits
AQUACULTURE et al. Applied Tropical Agriculture
Amezcua et al. Veterinary Therapeutics• Vol. 8, No. 3, Fall 2007